Possible effects of pandemic-related restrictions and adjustments in psychiatric treatment are currently the focus of interest. This article addresses developments in this respect in our clinic.

Changes in clinical practice that occurred during the COVID-19 pandemic are to be analysed with regard to possible risks for affected patients.

A clinic-internal analysis was carried out, focusing on comparing a period during the COVID-19 pandemic (01.11.2020-30.04.2021) and a pre-pandemic reference period (01.11.2018-30.04.2019).

Following trends were observed during the pandemic period: a. Day patient treatment: - The treatment volume fell to 44%. Notable reductions in the number of treatment cases with main diagnoses [ICD-10] F10.- and F30-F39 by >65% were measured. b. Inpatient treatment: - no significant changes regarding socio-demographic patient data and concerning the type of admission and discharge, - detection of coronavirus SARS-CoV-2 by PCR test in 4.7% of the cases, - a decline in the treatment volume to 87% due to 8% decrease in the number of cases and 5% decrease in the ALOS, with patients with the main diagnosis [ICD-10] F10.- were most affected, - increases regarding the percentage of cases with the main diagnosis [ICD-10] F40-F48 (p<0.05) and in the ALOS of this patient group (by 31%), - a significant rise (p< 0.01) in the ratio of restrained treatment cases.

Related to the decrease in treatment volume, the increase in psychiatric intensive treatment and possible risks in terms of the care situation for patients with the main diagnoses [ICD-10] F10.-, F30-F39 and F40-F48 should be discussed in particular.

No significant relationships.